Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.35 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | KDM5A | P29375 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20628161 | 0.87 | CA12 (0.37) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL25924428 | 0.86 | CA12 (0.36) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL24557245 | 0.84 | CA12 (0.35) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL24709510 | 0.83 | CA12 (0.34) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL20778802 | 0.82 | CA12 (0.33) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL20115513 | 0.82 | CES2 (0.36) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL27341113 | 0.82 | CES2 (0.33) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL22035307 | 0.80 | CES2 (0.32) | CA12CA1CA9CA2ZDHHC20 | |
| SCHEMBL21324002 | 0.78 | CES2 (0.31) | CA12CA1CA9CA2CES2 | |
| SCHEMBL22907293 | 0.78 | CES2 (0.31) | CA12CA1CA9CA2CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287088-A1 | BINDING AGENTS FOR CORONAVIRUS S PROTEIN | BioNTech SE (DE) | 2023-09-14 | — | — | US | disclosed |
| US-20210251898-A1 | LIPID NANOPARTICLE MRNA VACCINES | CUREVAC AG (DE) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287088-A1 | BINDING AGENTS FOR CORONAVIRUS S PROTEIN | SARS1, CD2BP2, RBM3 | CA12 2671/4885CA1 3712/4885CA9 3872/4885 |
| US-20210251898-A1 | LIPID NANOPARTICLE MRNA VACCINES | RNMT, PLIN3, SARNP | CA12 1306/4885CA1 2186/4885CA9 1876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.